World's Best Scientists 2026 revealed!
Andrew D. Badley

Andrew D. Badley

D-Index & Metrics

Immunology

D-Index
63
Citations
11887
World Ranking
3066
National Ranking
1435

Andrew D. Badley publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrew D. Badley sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 296 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrew D. Badley D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew D. Badley sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andrew D. Badley is affiliated with the Mayo Clinic in the United States and has a significant body of research concentrated in the field of Medicine. Their work spans several subfields including Infectious Diseases, Neurology, Molecular Biology, Oncology, and Immunology.

The scientist's research predominantly addresses COVID-19 and related topics. Major areas of study include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Vaccine Coverage and Hesitancy, COVID-19 and healthcare impacts, HIV Research and Treatment, and SARS-CoV-2 detection and testing.

Andrew D. Badley has contributed to multiple publications with frequent appearances in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Mayo Clinic Proceedings
  • SSRN Electronic Journal
  • EClinicalMedicine
  • PNAS Nexus

Frequent collaborators in their research include:

  • John C. O'Horo
  • Venky Soundararajan
  • AJ Venkatakrishnan
  • Arjun Puranik
  • Colin Pawlowski

Some of the recent papers authored by Andrew D. Badley include:

  • Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence (2021), bioRxiv (Cold Spring Harbor Laboratory)
  • FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system (2021), Med
  • Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis (2020), eLife
  • Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19 (2021), EClinicalMedicine
  • Multi-organ impairment in low-risk individuals with long COVID (2020), bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes.

    Andrew D. Badley;Julie A. McElhinny;Paul J. Leibson;David H. Lynch

  • Mechanisms of HIV-associated lymphocyte apoptosis.

    Andrew D. Badley;André A. Pilon;André A. Pilon;Alan Landay;Alan Landay;David H. Lynch;David H. Lynch

  • Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

    Luciléia Teixeira;Hernan Valdez;Joseph M. McCune;Richard A. Koup

  • Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor

    Andrew D. Badley;David Dockrell;Margaret Simpson;Ron Schut

  • Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis

    Julian J. Lum;Oren J. Cohen;Zilin Nie;Zilin Nie;Joel G. Weaver

  • Comparison of Two Highly-Effective mRNA Vaccines for COVID-19 During Periods of Alpha and Delta Variant Prevalence

    Arjun Puranik;Patrick Lenehan;Eli Silvert;Michiel Jm Niesen

  • Mechanisms of HIV-associated lymphocyte apoptosis: 2010.

    N W Cummins;A D Badley

  • Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation

    Robin Patel;Daniel Portela;Andrew D. Badley;William S. Harmsen

  • FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.

    Colin Pawlowski;Patrick Lenehan;Arjun Puranik;Vineet Agarwal

  • In vivo analysis of Fas/FasL interactions in HIV-infected patients.

    Andrew D. Badley;David H. Dockrell;Alicia Algeciras;Steve Ziesmer

  • The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

    David H. Dockrell;Andrew D. Badley;Jorge S. Villacian;Carrie J. Heppelmann

  • Seroconversion to Human Herpesvirus 6 following Liver Transplantation Is a Marker of Cytomegalovirus Disease

    David H. Dockrell;Jose Prada;Mary F. Jones;Robin Patel

  • HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation

    Z. Nie;Z. Nie;B. N. Phenix;B. N. Phenix;J. J. Lum;J. J. Lum;A. Alam

  • Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

    Julian J. Lum;André A. Pilon;Jaime Sanchez-Dardon;Barbara N. Phenix

  • Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss

    Barbara N. Phenix;Julian J. Lum;Zelin Nie;Jaime Sanchez-Dardon

  • MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates.

    Siobhan T. Pittock;Suzanne M. Norby;Joseph P. Grande;Anthony J. Croatt

  • Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.

    AD Badley;K Parato;DW Cameron;S Kravcik

  • Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.

    Raymund R Razonable;Colin F Pawlowski;John Charles O'Horo;Lori L Arndt

  • Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.

    B N Phenix;J B Angel;F Mandy;S Kravcik

  • Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations.

    Colin Pawlowski;Arjun Puranik;Hari Bandi;A. J. Venkatakrishnan

  • FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system

    Colin Pawlowski;Patrick Lenehan;Arjun Puranik;Vineet Agarwal

  • Apoptosis in AIDS

    Andrew D. Badley;David Dockrell;Carlos V. Paya

Frequent Co-Authors

Carlos V. Paya
Carlos V. Paya Eli Lilly (United States)
Gregory J. Gores
Gregory J. Gores Mayo Clinic
David H. Lynch
David H. Lynch ApoVax, Inc.
Jonathan B. Angel
Jonathan B. Angel University of Ottawa
Robin Patel
Robin Patel Mayo Clinic
Guido Kroemer
Guido Kroemer Université Paris Cité
Sharon R. Lewin
Sharon R. Lewin University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related degrees in nursing can broaden career opportunities. Many students begin with online rn programs for non nurses, which offer a flexible path to enter the healthcare field without prior nursing experience.

Accelerated programs like the easiest absn to get into are ideal for those with a non-nursing bachelor's degree who want to fast-track their nursing education and apply immunology knowledge clinically.

For a quicker entry into nursing, easy admission lpn programs provide foundational training that can serve as a stepping stone toward advanced immunology-related roles in patient care.

Finally, advancing to specialized roles in immunology often involves pursuing nurse practitioner degrees. Identifying which nurse practitioner program is easiest can help candidates balance rigorous study with career demands, ensuring a smooth transition to advanced clinical positions.

Best Scientists Citing Andrew D. Badley

Trending Scientists

Recently Published Articles